121 related articles for article (PubMed ID: 15357482)
1. [Qualitatively reliable study proves: in chronic bronchitis or COPD--standardized Myrtol].
MMW Fortschr Med; 2004 May; 146(19):56-7. PubMed ID: 15357482
[No Abstract] [Full Text] [Related]
2. Effect of Myrtol standardized on mucus hypersecretion and clearance of Pseudomonas aeruginosa in a rat model of chronic obstructive pulmonary disease.
Cao L; Chen Y; Zhao Y; Zhang H; Wang S; Wang Z; Kang J
Arzneimittelforschung; 2011; 61(12):685-92. PubMed ID: 22282955
[TBL] [Abstract][Full Text] [Related]
3. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
4. Erdosteine for COPD exacerbations.
Drug Ther Bull; 2008 Oct; 46(10):79-80. PubMed ID: 18832259
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators.
Meister R; Wittig T; Beuscher N; de Mey C
Arzneimittelforschung; 1999 Apr; 49(4):351-8. PubMed ID: 10337455
[TBL] [Abstract][Full Text] [Related]
6. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies.
El Moussaoui R; Roede BM; Speelman P; Bresser P; Prins JM; Bossuyt PM
Thorax; 2008 May; 63(5):415-22. PubMed ID: 18234905
[TBL] [Abstract][Full Text] [Related]
7. [Guidelines of the German Respiratory League. Mucolytic drugs now also have a place in therapy of COPD].
MMW Fortschr Med; 2002 Sep; 144(38):60. PubMed ID: 12395714
[No Abstract] [Full Text] [Related]
8. [Bronchitis and sinusitis. Effective treatment by stimulating mucociliary clearance].
MMW Fortschr Med; 2012 Nov; 154(20):70-1. PubMed ID: 23234125
[No Abstract] [Full Text] [Related]
9. Mucolytic agents for COPD and chronic bronchitis.
Molle E
Am J Nurs; 2013 Jul; 113(7):23. PubMed ID: 23803930
[TBL] [Abstract][Full Text] [Related]
10. Effect of myrtol on chronic bronchitis or chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis.
Liu L; Li S; Wu Y; Wang X; Huang D; Pei C; Wang F; Wang Z
Medicine (Baltimore); 2020 Jul; 99(28):e20692. PubMed ID: 32664065
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study of decoction of invigorating Qi and clearing lung combined standardized myrtol on acute exacerbation of chronic obstructive pulmonary disease (AECOPD)].
Hua ZQ; Chang YJ
Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(3):440-2. PubMed ID: 23668026
[TBL] [Abstract][Full Text] [Related]
12. Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis.
Cazzola M; Calzetta L; Page C; Rogliani P; Matera MG
Pulm Pharmacol Ther; 2018 Feb; 48():185-194. PubMed ID: 29233650
[TBL] [Abstract][Full Text] [Related]
13. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
[TBL] [Abstract][Full Text] [Related]
14. [The role of mucolytic therapy in the treatment of sinobronchial syndrome].
Zaĭtseva OV
Vestn Otorinolaringol; 2012; (2):63-5. PubMed ID: 22810642
[TBL] [Abstract][Full Text] [Related]
15. Wobenzym in treatment of recurrent obstructive bronchitis in children.
Lanchava N; Nemsadze K; Chkhaidze I; Kandelaki E; Nareklishvili N
Georgian Med News; 2005 Oct; (127):50-3. PubMed ID: 16308444
[TBL] [Abstract][Full Text] [Related]
16. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
Tashkin DP
Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
[TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses.
Papi A; Alfano F; Bigoni T; Mancini L; Mawass A; Baraldi F; Aljama C; Contoli M; Miravitlles M
Arch Bronconeumol; 2024 May; 60(5):269-278. PubMed ID: 38555190
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of a complementary antiinflammatory treatment with erespal in chronic obstructive and nonobstructive bronchitis].
Volkova LI; Budkova AA; Filonova NN; Khristoliubova EI; Kutuzova EB; Koroleva NV; Radzivil TT; Aminova ZR; Chuchalin AG
Ter Arkh; 2004; 76(8):51-6. PubMed ID: 15471398
[TBL] [Abstract][Full Text] [Related]
19. Carbocisteine for acute exacerbations of COPD.
Waller P; Suissa S
Lancet; 2008 Nov; 372(9650):1630; author reply 1631-2. PubMed ID: 18994655
[No Abstract] [Full Text] [Related]
20. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.
File TM; Monte SV; Schentag JJ; Paladino JA; Klugman KP; Lavin B; Yu VL; Singer ME; Adelman MH
Int J Antimicrob Agents; 2009 Jan; 33(1):58-64. PubMed ID: 18835762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
